Cargando…

Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report

BACKGROUND: IgG4-related disease often forms a mass and the affected lesion is clinically removed because the mass cannot be differentiated from a neoplasm. Affected lesions commonly occur in the pancreas, hepatobiliary tract, kidney, and retroperitoneum. However, the lesion rarely occurs in the thy...

Descripción completa

Detalles Bibliográficos
Autores principales: Masunaga, Atsuko, Ishibashi, Fumihiro, Koh, Eitetsu, Oide, Takashi, Sekine, Yasuo, Hiroshima, Kenzo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811959/
https://www.ncbi.nlm.nih.gov/pubmed/29439708
http://dx.doi.org/10.1186/s13000-018-0684-1
_version_ 1783299949508689920
author Masunaga, Atsuko
Ishibashi, Fumihiro
Koh, Eitetsu
Oide, Takashi
Sekine, Yasuo
Hiroshima, Kenzo
author_facet Masunaga, Atsuko
Ishibashi, Fumihiro
Koh, Eitetsu
Oide, Takashi
Sekine, Yasuo
Hiroshima, Kenzo
author_sort Masunaga, Atsuko
collection PubMed
description BACKGROUND: IgG4-related disease often forms a mass and the affected lesion is clinically removed because the mass cannot be differentiated from a neoplasm. Affected lesions commonly occur in the pancreas, hepatobiliary tract, kidney, and retroperitoneum. However, the lesion rarely occurs in the thymus. A histological worldwide consensus of IgG4-related disease proposed that pathological diagnosis of IgG4-related disease should meet more than two of three major features: 1) dense lymphoplasmacytic infiltration with greater than 40% IgG4+/IgG+ plasma cells, 2) storiform fibrosis; and 3) obliterative phlebitis. Currently, fibrosis of IgG4-related disease is thought to be induced by profibrotic cytokines such as transforming growth factor beta 1 (TGFB1), interleukin 1 beta (IL1B) and interferon gamma (IFNG), which are secreted by regulatory T cells (Tregs) and CD4-positive cytotoxic T cells. However, it is unclear whether profibrotic cytokines are associated with the fibrosis seen in IgG4-related thymitis. Here we examined whether cytokines in the mass were increased compared with those in the surrounding thymus, and whether Tregs were present in the mass, using reverse transcription absolute quantitative polymerase chain reaction (RT-ab-qPCR) and immunohistochemistry. CASE PRESENTATION: A 70-year-old Japanese man contracted IgG4-letated thymitis. Histological and immunohistochemical analyses demonstrated his mass had massive fibrosis with a focally storiform pattern and lymphoplasmacytic infiltration with 40% IgG4+/IgG+ plasma cells, but not obliterative phlebitis. The mass was surrounded by atrophic thymus. We diagnosed the mass as IgG4-related thymitis. Immunohistochemically, Tregs were scattered throughout the mass. RT-ab-qPCR showed that messenger RNA expressions of TGFB1, IL1B and IFNG in the mass were 270-, 158- and 5.5- fold higher than in the surrounding thymus. His serum IgG4 level after surgery was within the normal range (83.4 mg/dl soon after surgery, 89.3 mg/dl 2 weeks after surgery). CONCLUSIONS: Our results suggested the profibrotic cytokines TGFB1, IL1B and IFNG induce fibrosis and that Tregs might produce some of these cytokines in IgG4-related thymitis as well as in the other affected lesions of IgG4-related disease.
format Online
Article
Text
id pubmed-5811959
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-58119592018-02-15 Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report Masunaga, Atsuko Ishibashi, Fumihiro Koh, Eitetsu Oide, Takashi Sekine, Yasuo Hiroshima, Kenzo Diagn Pathol Case Report BACKGROUND: IgG4-related disease often forms a mass and the affected lesion is clinically removed because the mass cannot be differentiated from a neoplasm. Affected lesions commonly occur in the pancreas, hepatobiliary tract, kidney, and retroperitoneum. However, the lesion rarely occurs in the thymus. A histological worldwide consensus of IgG4-related disease proposed that pathological diagnosis of IgG4-related disease should meet more than two of three major features: 1) dense lymphoplasmacytic infiltration with greater than 40% IgG4+/IgG+ plasma cells, 2) storiform fibrosis; and 3) obliterative phlebitis. Currently, fibrosis of IgG4-related disease is thought to be induced by profibrotic cytokines such as transforming growth factor beta 1 (TGFB1), interleukin 1 beta (IL1B) and interferon gamma (IFNG), which are secreted by regulatory T cells (Tregs) and CD4-positive cytotoxic T cells. However, it is unclear whether profibrotic cytokines are associated with the fibrosis seen in IgG4-related thymitis. Here we examined whether cytokines in the mass were increased compared with those in the surrounding thymus, and whether Tregs were present in the mass, using reverse transcription absolute quantitative polymerase chain reaction (RT-ab-qPCR) and immunohistochemistry. CASE PRESENTATION: A 70-year-old Japanese man contracted IgG4-letated thymitis. Histological and immunohistochemical analyses demonstrated his mass had massive fibrosis with a focally storiform pattern and lymphoplasmacytic infiltration with 40% IgG4+/IgG+ plasma cells, but not obliterative phlebitis. The mass was surrounded by atrophic thymus. We diagnosed the mass as IgG4-related thymitis. Immunohistochemically, Tregs were scattered throughout the mass. RT-ab-qPCR showed that messenger RNA expressions of TGFB1, IL1B and IFNG in the mass were 270-, 158- and 5.5- fold higher than in the surrounding thymus. His serum IgG4 level after surgery was within the normal range (83.4 mg/dl soon after surgery, 89.3 mg/dl 2 weeks after surgery). CONCLUSIONS: Our results suggested the profibrotic cytokines TGFB1, IL1B and IFNG induce fibrosis and that Tregs might produce some of these cytokines in IgG4-related thymitis as well as in the other affected lesions of IgG4-related disease. BioMed Central 2018-01-17 /pmc/articles/PMC5811959/ /pubmed/29439708 http://dx.doi.org/10.1186/s13000-018-0684-1 Text en © The Author(s). 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Case Report
Masunaga, Atsuko
Ishibashi, Fumihiro
Koh, Eitetsu
Oide, Takashi
Sekine, Yasuo
Hiroshima, Kenzo
Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
title Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
title_full Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
title_fullStr Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
title_full_unstemmed Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
title_short Possible relationship between fibrosis of IgG4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
title_sort possible relationship between fibrosis of igg4-related thymitis and the profibrotic cytokines, transforming growth factor beta 1, interleukin 1 beta and interferon gamma: a case report
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5811959/
https://www.ncbi.nlm.nih.gov/pubmed/29439708
http://dx.doi.org/10.1186/s13000-018-0684-1
work_keys_str_mv AT masunagaatsuko possiblerelationshipbetweenfibrosisofigg4relatedthymitisandtheprofibroticcytokinestransforminggrowthfactorbeta1interleukin1betaandinterferongammaacasereport
AT ishibashifumihiro possiblerelationshipbetweenfibrosisofigg4relatedthymitisandtheprofibroticcytokinestransforminggrowthfactorbeta1interleukin1betaandinterferongammaacasereport
AT koheitetsu possiblerelationshipbetweenfibrosisofigg4relatedthymitisandtheprofibroticcytokinestransforminggrowthfactorbeta1interleukin1betaandinterferongammaacasereport
AT oidetakashi possiblerelationshipbetweenfibrosisofigg4relatedthymitisandtheprofibroticcytokinestransforminggrowthfactorbeta1interleukin1betaandinterferongammaacasereport
AT sekineyasuo possiblerelationshipbetweenfibrosisofigg4relatedthymitisandtheprofibroticcytokinestransforminggrowthfactorbeta1interleukin1betaandinterferongammaacasereport
AT hiroshimakenzo possiblerelationshipbetweenfibrosisofigg4relatedthymitisandtheprofibroticcytokinestransforminggrowthfactorbeta1interleukin1betaandinterferongammaacasereport